Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn’s disease

Abstract

Dual biologic therapy was associated with clinical, biomarker and endoscopic improvements in selected patients with refractory Crohn's disease who failed multiple biologics. Further studies are needed to validate this approach.